263 participants
A Phase 3 Study of Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-22
- Start Date:
- 2026-08-31
- Completion:
- 2028-09-30
Conditions
- Idiopathic Pulmonary Fibrosis (IPF)
Interventions
- DRUG
No Results Yet